Dr Reddys Laboratories

Forecast & Rating5 analysts currently cover Dr Reddys Laboratories, with about 40.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $13.55, about 10.6% upside from the current price of $12.25. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 91.7% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Dr Reddys Laboratories are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 4, 2026; for reference only and not investment advice.